Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA93817
Max Phase: Preclinical
Molecular Formula: C18H21N3
Molecular Weight: 279.39
Molecule Type: Small molecule
Associated Items:
ID: ALA93817
Max Phase: Preclinical
Molecular Formula: C18H21N3
Molecular Weight: 279.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C(#Cc1cn[nH]c1)CN1CCC(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C18H21N3/c1-2-5-16(6-3-1)13-17-8-11-21(12-9-17)10-4-7-18-14-19-20-15-18/h1-3,5-6,14-15,17H,8-13H2,(H,19,20)
Standard InChI Key: BHIIBEUBCSPDET-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 279.39 | Molecular Weight (Monoisotopic): 279.1735 | AlogP: 2.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 31.92 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.70 | CX LogP: 3.41 | CX LogD: 2.93 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.88 | Np Likeness Score: -1.08 |
1. Wright JL, Gregory TF, Boxer PA, Meltzer LT, Serpa KA, Wise LD.. (1999) Discovery of subtype-selective NMDA receptor ligands: 4-benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists., 9 (19): [PMID:10522697] [10.1016/s0960-894x(99)00482-5] |
Source(1):